Novel Therapies for Type 2 Diabetes

Highlighting new drug classes, such as SGLT-2 inhibitors and GLP-1 receptor agonists, and their impact on glucose control and cardiovascular outcomes. Several novel therapies have emerged in recent years for the treatment of type 2 diabetes. These therapies offer alternative mechanisms of action, improved efficacy, and reduced side effects compared to traditional treatment options.


  • Glucose-Lowering Medications
  • Personalized Medicine Approaches
  • Bariatric Surgery and Metabolic Interventions
  • Gut Microbiota and Probiotics
  • Regenerative Medicine and Stem Cell Therapies

Related Conference of Novel Therapies for Type 2 Diabetes

November 22-23, 2024

20th World Congress on Endocrinology & Diabetes

Amsterdam, Netherlands
November 27-28, 2024

14th World Congress on Endocrinology and Diabetes

Paris, France
February 24-25, 2025

34th European Diabetes Congress

London, UK
March 10-11, 2025

4th Global Summit on Physiology and Metabolism of Thyroid

Singapore City, Singapore
March 17-18, 2025

5th European Endocrinology and Diabetes Congress

Paris, France
April 10-11, 2025

4th International Summit on Hormonal Disorders

Dubai, UAE
April 10-11, 2025

5th World Congress on Endocrine and Diabetes

Dubai, UAE
May 19-20, 2025

6th World Summit on Diabetes

Rome, Italy
June 04-05, 2025

4th World Congress on Diabetes and Pediatric Endocrinology

Edinburgh, Scotland

Novel Therapies for Type 2 Diabetes Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in